Optimizing Viral Clearance in Continuous Manufacturing: Strategies for Enhanced Efficiency and Regulatory Compliance

Join WuXi Biologics and Cell Culture Dish for an insightful webinar. Presented by Dr. Yuanyuan Chen, Senior Director, WuXi Biologics, this session explores how viral clearance critically impacts continuous manufacturing, with an emphasis on meeting key regulatory guidelines. Continuous manufacturing runs nonstop, making the removal or inactivation of viral contaminants in biologic products particularly challenging. Dr. Chen discusses the complexities involved in designing viral clearance studies for continuous processes, focusing on technical hurdles like scale-down models, virus spiking strategies, and sample representativeness. Attendees gain practical insights into innovative solutions supported by real-world case studies.

The webinar also showcases advancements in viral clearance during continuous capture, where resin usage rates increased from 60% to 95%, significantly boosting efficiency. Dr. Chen highlights how WuXi Biologics successfully implemented continuous virus filtration systems that operated for over 200 hours without viral breakthrough, demonstrating the effectiveness of long-term filtration strategies. Viewers will leave with a deeper understanding of how to optimize viral clearance, maintain regulatory compliance, and ensure product quality throughout the continuous manufacturing process.

To watch the webinar, please see Viral Clearance Study for Continuous Manufacturing: Challenges and Solutions

Pin It on Pinterest